4.79
price down icon2.44%   -0.12
pre-market  Pre-mercato:  4.79  
loading
Precedente Chiudi:
$4.91
Aprire:
$4.91
Volume 24 ore:
5.07M
Relative Volume:
1.23
Capitalizzazione di mercato:
$1.12B
Reddito:
$251.85M
Utile/perdita netta:
$-72.58M
Rapporto P/E:
-15.28
EPS:
-0.3134
Flusso di cassa netto:
$-63.80M
1 W Prestazione:
-7.71%
1M Prestazione:
-10.63%
6M Prestazione:
-30.07%
1 anno Prestazione:
-35.36%
Intervallo 1D:
Value
$4.745
$4.95
Intervallo di 1 settimana:
Value
$4.675
$5.23
Portata 52W:
Value
$4.32
$9.33

Ardelyx Inc Stock (ARDX) Company Profile

Name
Nome
Ardelyx Inc
Name
Telefono
510-745-7047
Name
Indirizzo
34175 ARDENWOOD BLVD., FREMONT, CA
Name
Dipendente
267
Name
Cinguettio
@ardelyx
Name
Prossima data di guadagno
2024-10-31
Name
Ultimi documenti SEC
Name
ARDX's Discussions on Twitter

Confronta ARDX con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
ARDX
Ardelyx Inc
4.79 1.12B 251.85M -72.58M -63.80M -0.3134
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
484.74 124.48B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
617.00 67.45B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
567.09 34.59B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
255.76 33.10B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
271.04 29.15B 3.81B -644.79M -669.77M -6.24

Ardelyx Inc Stock (ARDX) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-03-07 Ripresa Ladenburg Thalmann Buy
2025-03-04 Iniziato BTIG Research Buy
2024-11-11 Downgrade H.C. Wainwright Buy → Neutral
2024-07-02 Downgrade Piper Sandler Overweight → Neutral
2024-04-05 Iniziato Leerink Partners Outperform
2023-12-18 Iniziato Raymond James Strong Buy
2023-09-07 Iniziato H.C. Wainwright Buy
2023-08-25 Aggiornamento Cantor Fitzgerald Neutral → Overweight
2023-03-03 Aggiornamento Wedbush Neutral → Outperform
2022-11-17 Aggiornamento Piper Sandler Neutral → Overweight
2022-05-06 Downgrade Cantor Fitzgerald Overweight → Neutral
2021-12-01 Aggiornamento Ladenburg Thalmann Neutral → Buy
2021-10-14 Downgrade Ladenburg Thalmann Buy → Neutral
2021-07-21 Downgrade Jefferies Buy → Hold
2021-07-20 Downgrade Piper Sandler Overweight → Neutral
2021-07-20 Downgrade Wedbush Outperform → Neutral
2021-03-23 Iniziato Wedbush Outperform
2021-01-06 Iniziato Cantor Fitzgerald Overweight
2020-10-20 Ripresa Citigroup Buy
2020-02-18 Ripresa Jefferies Buy
2020-02-12 Iniziato Citigroup Buy
2020-02-10 Iniziato Cowen Outperform
2019-04-08 Iniziato Piper Jaffray Overweight
2018-08-24 Iniziato Jefferies Buy
2018-03-19 Ripresa Leerink Partners Outperform
2017-11-29 Reiterato Citigroup Buy
2017-11-22 Reiterato Ladenburg Thalmann Buy
2017-10-17 Ripresa Leerink Partners Outperform
2016-03-31 Iniziato Ladenburg Thalmann Buy
2016-03-09 Iniziato Cantor Fitzgerald Buy
2016-03-03 Iniziato Citigroup Buy
Mostra tutto

Ardelyx Inc Borsa (ARDX) Ultime notizie

pulisher
Mar 31, 2025

Ardelyx to Share a Post-Hoc Analysis of the OPTIMIZE Study Supporting XPHOZAH® (tenapanor) at the National Kidney Foundation Spring Clinical Meetings - The Manila Times

Mar 31, 2025
pulisher
Mar 31, 2025

First-in-Class Kidney Disease Drug XPHOZAH Reveals Breakthrough Clinical Results - Stock Titan

Mar 31, 2025
pulisher
Mar 31, 2025

Commit To Purchase Ardelyx At $4, Earn 20.5% Annualized Using Options - Nasdaq

Mar 31, 2025
pulisher
Mar 28, 2025

Institutional owners may take dramatic actions as Ardelyx, Inc.'s (NASDAQ:ARDX) recent 6.4% drop adds to one-year losses - simplywall.st

Mar 28, 2025
pulisher
Mar 27, 2025

How to Take Advantage of moves in (ARDX) - news.stocktradersdaily.com

Mar 27, 2025
pulisher
Mar 25, 2025

Shareholders that lost money on Ardelyx, Inc.(ARDX) should contact Levi & Korsinsky about pending Class ActionARDX - ACCESS Newswire

Mar 25, 2025
pulisher
Mar 20, 2025

Ardelyx Requests to Dismiss Class Action Filed by Investors - TradingView

Mar 20, 2025
pulisher
Mar 20, 2025

DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ardelyx - Marketscreener.com

Mar 20, 2025
pulisher
Mar 19, 2025

ARDELYX INC- The GF Score's 5 Key Aspects of Analysis - GuruFocus.com

Mar 19, 2025
pulisher
Mar 17, 2025

Trading (ARDX) With Integrated Risk Controls - news.stocktradersdaily.com

Mar 17, 2025
pulisher
Mar 13, 2025

Ardelyx honors inaugural Derek Forfang award winners By Investing.com - Investing.com Australia

Mar 13, 2025
pulisher
Mar 13, 2025

Ardelyx at Barclays Conference: Pipeline Expansion and Revenue Growth - Investing.com

Mar 13, 2025
pulisher
Mar 13, 2025

Ardelyx at Barclays Conference: Pipeline Expansion and Revenue Growth By Investing.com - Investing.com UK

Mar 13, 2025
pulisher
Mar 13, 2025

Ardelyx honors inaugural Derek Forfang award winners - Investing.com India

Mar 13, 2025
pulisher
Mar 13, 2025

Ardelyx Announces the First Recipients of Derek Forfang Patient Advocate Award - The Manila Times

Mar 13, 2025
pulisher
Mar 13, 2025

Five Champions of Kidney Disease Advocacy Receive Groundbreaking Ardelyx Recognition - StockTitan

Mar 13, 2025
pulisher
Mar 12, 2025

Insider Buying: David Mott Acquires Shares of Ardelyx Inc (ARDX) - GuruFocus.com

Mar 12, 2025
pulisher
Mar 12, 2025

Piper Sandler maintains $8 target on Ardelyx shares amid uncertainty By Investing.com - Investing.com South Africa

Mar 12, 2025
pulisher
Mar 12, 2025

Piper Sandler maintains $8 target on Ardelyx shares amid uncertainty - Investing.com India

Mar 12, 2025
pulisher
Mar 12, 2025

8,020 Shares in Ardelyx, Inc. (NASDAQ:ARDX) Bought by SBI Securities Co. Ltd. - Defense World

Mar 12, 2025
pulisher
Mar 12, 2025

Ardelyx at Leerink Global Healthcare Conference: Navigating Challenges and Opportunities By Investing.com - Investing.com South Africa

Mar 12, 2025
pulisher
Mar 11, 2025

Ardelyx at Leerink Global Healthcare Conference: Navigating Challenges and Opportunities - Investing.com India

Mar 11, 2025
pulisher
Mar 10, 2025

High Growth Tech Stocks In The US With Promising Potential - Simply Wall St

Mar 10, 2025
pulisher
Mar 09, 2025

Ardelyx (NASDAQ:ARDX) Earns “Buy” Rating from LADENBURG THALM/SH SH - Defense World

Mar 09, 2025
pulisher
Mar 08, 2025

Scotiabank Initiates Coverage of Ardelyx (ARDX) with Sector Outperform Recommendation - Nasdaq

Mar 08, 2025
pulisher
Mar 07, 2025

Ardelyx CEO Michael Raab sells $223,198 in stock - Investing.com

Mar 07, 2025
pulisher
Mar 07, 2025

Scotiabank sets $15 target for Ardelyx stock, sees growth potential - Investing.com

Mar 07, 2025
pulisher
Mar 07, 2025

Scotiabank sets $15 target for Ardelyx stock, sees growth potential By Investing.com - Investing.com South Africa

Mar 07, 2025
pulisher
Mar 07, 2025

Ardelyx, Inc. to Host Earnings Call - ACCESS Newswire

Mar 07, 2025
pulisher
Mar 07, 2025

Cantor Fitzgerald Predicts Ardelyx FY2025 Earnings - Defense World

Mar 07, 2025
pulisher
Mar 06, 2025

Ardelyx (NASDAQ:ARDX) Raised to Strong-Buy at Cantor Fitzgerald - Defense World

Mar 06, 2025
pulisher
Mar 05, 2025

Rhumbline Advisers Purchases 6,070 Shares of Ardelyx, Inc. (NASDAQ:ARDX) - Defense World

Mar 05, 2025
pulisher
Mar 05, 2025

Ardelyx (NASDAQ:ARDX) Coverage Initiated by Analysts at BTIG Research - Defense World

Mar 05, 2025
pulisher
Mar 04, 2025

BTIG sets Ardelyx stock Buy rating, $14 price target - Investing.com India

Mar 04, 2025
pulisher
Mar 04, 2025

BTIG sets Ardelyx stock Buy rating, $14 price target By Investing.com - Investing.com South Africa

Mar 04, 2025
pulisher
Mar 04, 2025

BTIG Initiates Ardelyx at Buy With $14 Price Target -March 04, 2025 at 07:10 am EST - Marketscreener.com

Mar 04, 2025
pulisher
Mar 04, 2025

BTIG initiates Ardelyx with a Buy, sees attractive entry point after pullback - TipRanks

Mar 04, 2025
pulisher
Mar 04, 2025

Class Action Filed Against Ardelyx, Inc. (ARDX) Seeking Recovery for InvestorsContact Levi & Korsinsky - ACCESS Newswire

Mar 04, 2025
pulisher
Mar 03, 2025

Ardelyx, Inc. Sued for Securities Law ViolationsContact Levi & Korsinsky Before October 15, 2024 to Discuss Your RightsARDX - ACCESS Newswire

Mar 03, 2025
pulisher
Mar 03, 2025

Lost Money on Ardelyx, Inc.(ARDX)? Join Class Action Suit Seeking Recovery – Contact Levi & Korsinsky - ACCESS Newswire

Mar 03, 2025
pulisher
Mar 02, 2025

Reviewing Q32 Bio (NASDAQ:QTTB) & Ardelyx (NASDAQ:ARDX) - Defense World

Mar 02, 2025
pulisher
Mar 01, 2025

Shareholders That Lost Money on Ardelyx, Inc. (ARDX) Should Contact Levi & Korsinsky About Pending Class ActionARDX - ACCESS Newswire

Mar 01, 2025
pulisher
Mar 01, 2025

Undercovered Dozen: Ardelyx, Aviva, Nutrien, Heartland Express + - Seeking Alpha

Mar 01, 2025
pulisher
Feb 28, 2025

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ardelyx - ACCESS Newswire

Feb 28, 2025
pulisher
Feb 28, 2025

Los Angeles Capital Management LLC Has $2.38 Million Stock Position in Ardelyx, Inc. (NASDAQ:ARDX) - MarketBeat

Feb 28, 2025
pulisher
Feb 28, 2025

Ardelyx (NASDAQ:ARDX) Stock Price Up 5.3% on Insider Buying Activity - MarketBeat

Feb 28, 2025
pulisher
Feb 28, 2025

ARDX LAWSUIT ALERT: Levi & Korsinsky Notifies Ardelyx, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - ACCESS Newswire

Feb 28, 2025
pulisher
Feb 28, 2025

Shareholders of Ardelyx, Inc. Should Contact Levi & Korsinsky Before October 15, 2024 to Discuss Your RightsARDX - ACCESS Newswire

Feb 28, 2025
pulisher
Feb 28, 2025

ARDX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Ardelyx, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

Feb 28, 2025
pulisher
Feb 28, 2025

Levi & Korsinsky Reminds Ardelyx Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 15, 2024ARDX - ACCESS Newswire

Feb 28, 2025
pulisher
Feb 27, 2025

Shareholders that lost money on Ardelyx, Inc. (ARDX) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire

Feb 27, 2025

Ardelyx Inc Azioni (ARDX) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$67.94
price down icon 3.89%
$72.00
price down icon 5.62%
$31.17
price up icon 0.13%
$18.80
price down icon 2.54%
$90.29
price down icon 0.85%
biotechnology ONC
$271.04
price down icon 0.42%
Capitalizzazione:     |  Volume (24 ore):